Background: Skin lesions from graft-versus-host disease (GVHD) show histological features of epidermal cell death with lymphocyte infiltration. Perforin and granzyme B are involved in the process of apoptosis induced by cytotoxic T lymphocytes (CTL). Objective: To elucidate the role of CTL in the mechanism of epidermal injury in GVHD. Methods: We studied immunohistochemical staining for granzyme B and perforin in the skin lesions of 8 patients who developed GVHD after bone marrow transplantation. Results: Granzyme-B-positive lymphocytes were CD8 positive and were observed in the epidermis of 3 out of 6 specimens in acute GVHD, and of 5 specimens of chronic GVHD except for 1 sclerotic type in which it was negative. Perforin-positive lymphocytes were observed in the epidermis of the specimens from 1 acute and 1 chronic GVHD. Conclusions: Granzyme B derived from CTL may be involved in the mechanisms of epidermal injury in GVHD.

Keywords:
Graft-versus-host disease, Perforin, Granzyme B, Apoptosis, Cytotoxic T lymphocytes
1.
Weedon D, Seaele J, Kerr JFR: Apoptosis: Its nature and implications for dermatopathology. Am J Dermatopathol 1979;1:133–144.
2.
De Dobbeleer GD, Ledoux-Corbusier MH, Achten GA: Graft versus host reaction: An ultrastructural study. Arch Dermatol 1975;111:1597–1602.
3.
Janin-Mercier A, Saurat JH, Bourges M, Sohier J, Didierjean L, Gluckman E: The lichen planus like and sclerotic phases of the graft-versus-host disease in man: An ultrastructural study of six cases. Acta Derm Venereol (Stockh) 1981;61:187–193.
4.
Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H: Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996;14:207–232.
5.
Graubert TA, Russell JH, Ley TJ: The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996;87:1232–1237.
6.
Graubert TA, DiPersio JF, Russell JH, Ley TJ: Perforin/granzyme dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 1997;100:904–911.
7.
Takata M: Immunohistochemical identification of perforin-positive cytotoxic lymphocytes in graft-versus-host disease. Am J Clin Pathol 1995;103:324–329.
8.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED: Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825–828.
9.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED: Chronic graft-versus-host syndrome in men: A long-term clinicopathological study of Seattle patients. Am J Med 1980;69:204–217.
10.
Legros-Maïda S, Soulié A, Benvenuti C, Wargnier A, Vallée N, Berthou C, Guillet J, Sasportes M, Sigaux N: Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation. Eur J Immunol 1994;24:229–233.
11.
Clément MV, Legros-Maïda S, Israël-Biet D, Carnot F, Soulié A, Reynaud P, Guillet J, Grandjbakch I, Sasportes M: Perforin and granzyme B expression is associated with severe acute rejection: Evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients. Transplantation 1994;57:322–326.
12.
Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED: Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974;6:367–371.
13.
Langley RGB, Walsh N, Neville T, Thomas L, Rowden G: Apoptosis is the mode of keratinocyte death in cutaneous graft-versus-host disease. J Am Acad Dermatol 1996;35:187–190.
14.
Hattori K, Hirano T, Miyajima H, Yamakawa N, Tateno M, Oshimi K, Kayagaki N, Yagita H, Okumura K: Differential effects of anti Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies. Blood 1998;91:4051–4055.
15.
Facon T, Jouet JP, Noel-Walter MP, Bloget F, Bauters F, Janin A: Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transplant 1997;20:511–515.
16.
Vogelsang GB, Hess AD: Graft-versus-host disease: New directions for a persistent problem. Blood 1994;84:2061–2067.
17.
Shimizu M, Higaki Y, Higaki M, Kawashima M: The role of granzyme B-expressing CD 8 positive T cells on apoptosis of keratinocytes in lichen planus. Arch Dermatol Res 1997;289:527–532.
18.
Saurat JH, Gluckman E: Lichen-planus-like eruption following bone marrow transplantation. A manifestation of the graft-versus-host disease. Clin Exp Dermatol 1977;2:335–344.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.